CASI PHARMACEUTICALS, INC. Depreciation
CASI PHARMACEUTICALS, INC. reported Depreciation of $389.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2020-11-09
- CASI PHARMACEUTICALS, INC. depreciation for the quarter ending 2020-09-30 was $113.00K.
- CASI PHARMACEUTICALS, INC. depreciation for the quarter ending 2020-06-30 was $130.00K, a 73.20% decline year-over-year.
- CASI PHARMACEUTICALS, INC. depreciation for the quarter ending 2020-03-31 was $146.00K, a 5.04% increase year-over-year.
- CASI PHARMACEUTICALS, INC. depreciation for the quarter ending 2019-12-31 was $42.00K, a 63.79% decline year-over-year.
- CASI PHARMACEUTICALS, INC. depreciation for fiscal 2019 was $603.00K, a 64.75% increase from fiscal 2018.
- CASI PHARMACEUTICALS, INC. depreciation for fiscal 2018 was $366.00K.
- CASI PHARMACEUTICALS, INC. depreciation for fiscal 2012 was $20.46K, a 46.33% decline from fiscal 2011.
- CASI PHARMACEUTICALS, INC. depreciation for fiscal 2011 was $38.12K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2020-09-30 | $113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $243.00K derived: sum of 2 quarters · filed 2020-11-09 | $389.00K 10-Q · filed 2020-11-09 | $431.00K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2020-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $276.00K 10-Q · filed 2020-08-10 | $318.00K derived: sum of 3 quarters · filed 2020-08-10 | $255.00K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2020-03-31 | $146.00K 10-Q · filed 2020-05-11 | $188.00K derived: sum of 2 quarters · filed 2020-05-11 | $125.00K derived: sum of 3 quarters · filed 2020-11-09 | $610.00K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$21.00K derived: sum of 2 quarters · filed 2020-11-09 | $464.00K derived: sum of 3 quarters · filed 2020-11-09 | $603.00K 10-K · filed 2020-03-16 | |
| 2019-09-30 | -$63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $422.00K derived: sum of 2 quarters · filed 2020-11-09 | $561.00K 10-Q · filed 2020-11-09 | $677.00K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $485.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $624.00K 10-Q · filed 2020-08-10 | $624.01K 10-Q · filed 2019-08-09 | $740.00K derived: sum of 3 quarters · filed 2020-08-10 | $848.28K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $139.00K 10-Q · filed 2020-05-11 | $255.00K derived: sum of 2 quarters · filed 2020-05-11 | $363.28K derived: sum of 3 quarters · filed 2020-05-11 | ||
| 2018-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $224.28K derived: sum of 2 quarters · filed 2020-03-16 | $366.00K 10-K · filed 2020-03-16 | ||
| 2018-09-30 | $108.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $250.00K 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $141.72K 10-Q · filed 2019-08-09 | ||||
| 2012-12-31 | $20.46K 10-K · filed 2013-03-21 | ||||
| 2011-12-31 | $38.12K 10-K · filed 2013-03-21 |